Author
Listed:
- Megumi Shiota
(FUJIFILM Corporation)
- Masayuki Naya
(FUJIFILM Corporation)
- Takehiro Yamamoto
(Keio University School of Medicine)
- Takako Hishiki
(Keio University School of Medicine)
- Takeharu Tani
(FUJIFILM Corporation)
- Hiroyuki Takahashi
(FUJIFILM Corporation)
- Akiko Kubo
(Keio University School of Medicine)
- Daisuke Koike
(FUJIFILM Business Expert Corporation)
- Mai Itoh
(Keio University School of Medicine)
- Mitsuyo Ohmura
(Keio University School of Medicine)
- Yasuaki Kabe
(Keio University School of Medicine)
- Yuki Sugiura
(Keio University School of Medicine)
- Nobuyoshi Hiraoka
(National Cancer Center Research Institute)
- Takayuki Morikawa
(National Center for Global Health and Medicine)
- Keiyo Takubo
(National Center for Global Health and Medicine)
- Kentaro Suina
(Keio University School of Medicine)
- Hideaki Nagashima
(Keio University School of Medicine)
- Oltea Sampetrean
(Keio University School of Medicine)
- Osamu Nagano
(Keio University School of Medicine)
- Hideyuki Saya
(Keio University School of Medicine)
- Shogo Yamazoe
(FUJIFILM Corporation)
- Hiroyuki Watanabe
(FUJIFILM Corporation)
- Makoto Suematsu
(Keio University School of Medicine)
Abstract
Gold deposition with diagonal angle towards boehmite-based nanostructure creates random arrays of horse-bean-shaped nanostructures named gold-nanofève (GNF). GNF generates many electromagnetic hotspots as surface-enhanced Raman spectroscopy (SERS) excitation sources, and enables large-area visualization of molecular vibration fingerprints of metabolites in human cancer xenografts in livers of immunodeficient mice with sufficient sensitivity and uniformity. Differential screening of GNF-SERS signals in tumours and those in parenchyma demarcated tumour boundaries in liver tissues. Furthermore, GNF-SERS combined with quantum chemical calculation identified cysteine-derived glutathione and hypotaurine (HT) as tumour-dominant and parenchyma-dominant metabolites, respectively. CD44 knockdown in cancer diminished glutathione, but not HT in tumours. Mechanisms whereby tumours sustained HT under CD44-knockdown conditions include upregulation of PHGDH, PSAT1 and PSPH that drove glycolysis-dependent activation of serine/glycine-cleavage systems to provide one-methyl group for HT synthesis. HT was rapidly converted into taurine in cancer cells, suggesting that HT is a robust anti-oxidant for their survival under glutathione-suppressed conditions.
Suggested Citation
Megumi Shiota & Masayuki Naya & Takehiro Yamamoto & Takako Hishiki & Takeharu Tani & Hiroyuki Takahashi & Akiko Kubo & Daisuke Koike & Mai Itoh & Mitsuyo Ohmura & Yasuaki Kabe & Yuki Sugiura & Nobuyos, 2018.
"Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival,"
Nature Communications, Nature, vol. 9(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03899-1
DOI: 10.1038/s41467-018-03899-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03899-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.